Stocks
AnaptysBio (ANAB) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -1.95 | 4.01 | 2.39 | -2.53 | 8.67 | 30.8 | ||
| Changes by years, y/y, % | -1 919% | -306% | -40% | -206% | -443% | +140.9% | |||
AnaptysBio. EV/EBITDA
AnaptysBio. EV/EBITDA, changes, %
AnaptysBio (ANAB) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -0.72 | -2.95 | -151.1 | 12.7 | 18.0 | 30.8 | |
| Changes by years, y/y, % | -471% | -223% | +8 026% | +1 069% | -2 582% | |||
| Changes by quarters, q/q, % | -167% | +307% | +5 029% | -108% | +42% | |||
